Walleye Trading
ACHN

Walleye Trading’s Achillion Pharmaceuticals ACHN Stock Holding History

Walleye Trading’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-202,900
Closed -$1.22M – 4908
2019
Q4 		$1.22M Buy
+202,900
New +$1.17M 0.01% 1620

Walleye Trading's ACHN Position: Q1 2020 in Review

Walleye Trading sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 368,443 shares — an estimated $2.22M sold.

Walleye Trading first reported a position in ACHN in Q2 2015 and held it in 4 quarters. The position peaked at $2.22M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Walleye Trading reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Walleye Trading sold 368,443 Achillion Pharmaceuticals shares in Q1 2020, an estimated $2.22M.
  • Walleye Trading first reported a position in Achillion Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Walleye Trading's Achillion Pharmaceuticals position peaked at $2.22M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.